Fibrates News and Research

RSS
Compounds that bock nutrient-sensing receptor may impact obesity and diabetic conditions

Compounds that bock nutrient-sensing receptor may impact obesity and diabetic conditions

Common food additive lecithin may help control blood lipids and reduce disease risk

Common food additive lecithin may help control blood lipids and reduce disease risk

90 per cent of the world's population won't have access to antivirals in pandemic - generic drugs may help though

90 per cent of the world's population won't have access to antivirals in pandemic - generic drugs may help though

In lab supplements of lipoic acid lower triglyceride levels

In lab supplements of lipoic acid lower triglyceride levels

NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management

NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management

VAP cholesterol test helps find link between a rare gene mutation and heart protection

VAP cholesterol test helps find link between a rare gene mutation and heart protection

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Crestor (rosuvastatin calcium) shown to significantly reduce major cardiovascular events

Fenofibrate intervention and event lowering in diabetes

Fenofibrate intervention and event lowering in diabetes

Abbott and AstraZeneca confirm Phase III clinical trials of Fenofibrate ABT-335 and Crestor as fixed-dose combination

Abbott and AstraZeneca confirm Phase III clinical trials of Fenofibrate ABT-335 and Crestor as fixed-dose combination

Caution urged on use of drugs to raise "good" cholesterol

Caution urged on use of drugs to raise "good" cholesterol

Regular exercise increases "good" cholesterol

Regular exercise increases "good" cholesterol

New drug combo to cut cardiovascular disease

New drug combo to cut cardiovascular disease

Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease

Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease

Cholesterol lowering drugs do not appear to decrease the risk of melanoma

Cholesterol lowering drugs do not appear to decrease the risk of melanoma

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

Actos reduces the combined risk of non-fatal heart attacks, strokes in patients with type-2 diabetes

HDL cholesterol helps prevent blocked arteries and heart attack

HDL cholesterol helps prevent blocked arteries and heart attack

Information about serious adverse effects of cerivastatin were known within months after drug launched

Information about serious adverse effects of cerivastatin were known within months after drug launched

Patients taking the lipid-lowering medications have a relatively low risk of developing rhabdomyolysis

Patients taking the lipid-lowering medications have a relatively low risk of developing rhabdomyolysis

Zetia co-administered with Fenofibrate significantly reduced LDL ("bad") cholesterol in mixed hyperlipidemia patients

Zetia co-administered with Fenofibrate significantly reduced LDL ("bad") cholesterol in mixed hyperlipidemia patients

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol